Centrally acting ACE inhibitor (cACEi) and angiotensin receptor blocker (cARB) use and cognitive dysfunction in patients with SLE

OBJECTIVE: Cognitive dysfunction (CD) is detectable in approximately 40% of patients with SLE. Despite this high prevalence, there are no approved pharmacological treatment options for this detrimental condition. Preliminary murine studies show potential for targeting microglial activation as a trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Dobrowolski, Chrisanna, Barraclough, Michelle, Su, Jiandong, Tanic, Milica, Bingham, Kathleen, Ruttan, Lesley, Beaton, Dorcas, Wither, Joan, Tartaglia, Maria Carmela, Sano, Mary, Kakvan, Mahta, Bonilla, Dennisse, Green, Robin, Touma, Zahi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Epidemiology and Outcomes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335417/
https://www.ncbi.nlm.nih.gov/pubmed/37429671
http://dx.doi.org/10.1136/lupus-2023-000923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335417/
https://www.ncbi.nlm.nih.gov/pubmed/37429671
http://dx.doi.org/10.1136/lupus-2023-000923

Ejemplares similares